HeartSciences Inc. Fundamental Analysis (NASDAQ: HSCSW)
HeartSciences Inc. (NASDAQ: HSCSW) shows weak financial fundamentals with a PE ratio of -0.53, profit margin of -2116.66%, and ROE of -3.58%. The company generates $0.0B in annual revenue with weak year-over-year growth of -76.61%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -159176.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HSCSW's fundamental strength across five key dimensions:
Efficiency Score
WeakHSCSW struggles to generate sufficient returns from assets.
Valuation Score
ExcellentHSCSW trades at attractive valuation levels.
Growth Score
ModerateHSCSW shows steady but slowing expansion.
Financial Health Score
WeakHSCSW carries high financial risk with limited liquidity.
Profitability Score
WeakHSCSW struggles to sustain strong margins.
Key Financial Metrics
Is HSCSW Expensive or Cheap?
P/E Ratio
HSCSW trades at -0.53 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, HSCSW's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values HeartSciences Inc. at 28.82 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -197.00 times EBITDA. This is generally considered low.
How Well Does HSCSW Make Money?
Net Profit Margin
For every $100 in sales, HeartSciences Inc. keeps $-2116.66 as profit after all expenses.
Operating Margin
Core operations generate -1947.87 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-3.58 in profit for every $100 of shareholder equity.
ROA
HeartSciences Inc. generates $-1.74 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
HeartSciences Inc. generates strong operating cash flow of $18.58M, reflecting robust business health.
Free Cash Flow
HeartSciences Inc. generates strong free cash flow of $10.57M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $3.99 in free cash annually.
FCF Yield
HSCSW converts 2.84% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.53
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
28.82
vs 25 benchmark
P/S Ratio
Price to sales ratio
1030.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
17.41
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.50
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-3.58
vs 25 benchmark
ROA
Return on assets percentage
-1.74
vs 25 benchmark
ROCE
Return on capital employed
-20.95
vs 25 benchmark
How HSCSW Stacks Against Its Sector Peers
| Metric | HSCSW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.53 | 29.66 | Better (Cheaper) |
| ROE | -358.44% | 516.00% | Weak |
| Net Margin | -211666.47% | -11488.00% (disorted) | Weak |
| Debt/Equity | 17.41 | 0.78 | Weak (High Leverage) |
| Current Ratio | 0.50 | 5.26 | Weak Liquidity |
| ROA | -173.71% | 2938616.00% | Weak |
HSCSW outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews HeartSciences Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-99.76%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
91.88%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
93.18%
Industry Style: Defensive, Growth, Innovation
High Growth